The current valuation score of Aquestive Therapeutics Inc is 8.87, ranking 63 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -7.73, which is -91.60% below the recent high of -0.65 and -513.06% above the recent low of -47.40.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.